Hilary Vernon
Pediatrics · Baltimore, MDNPI 1245380047
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,887 of the $3,025 with a category attached, or 95.4%. Modernatx, Inc. accounts for 69.4% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $2,138, 5.0 times the $426 reported in 2019. Among pediatrics clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $336.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2K
- Alnylam Pharmaceuticals Inc.$401
- Eagle Pharmaceuticals, Inc.$386
- AstraZeneca$61
- UCB, Inc.$38
- Biomarin Pharmaceutical Inc.$24
- plus $15 from 1 others
Across 81 payments — averaging $4053.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- PTC Therapeutics, Inc.$153K
- Modernatx, Inc.$139K
- Biomarin Pharmaceutical Inc.$32K
- Shire North American Group Inc$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Consulting fees$2,88795%
- Food & beverage$1244%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 1 | $2,100 |
| Alnylam Pharmaceuticals Inc. | 1 | $401 |
| Eagle Pharmaceuticals, Inc. | 1 | $386 |
| AstraZeneca | 1 | $61 |
| UCB, Inc. | 1 | $38 |
| Biomarin Pharmaceutical Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 3 | $15 |
How this compares
$3,025 in reported general payments places this provider in the 95th percentile of 1,307 pediatrics providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Leucovorin Calcium | 20 | $2,540 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Baltimore
- Mary Elizabeth YoungerBaltimore$130K
- Brenda BanwellBaltimore$109K
- John ThomsonBaltimore$67K
- Carmelo CuffariBaltimore$61K
- Deborah PersaudBaltimore$22K
- Eric McCollumBaltimore$18K
- Irini BatsisBaltimore$14K
- Kim DrucisBaltimore$10K
- Maria TrentBaltimore$9K
- Nicole Salazar AustinBaltimore$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.